Skip to main content

Longitudinal surveys of prevalence rates and use patterns of illicit drugs at selected high-prevalence areas in China from 1993 to 2000

Buy Article:

$51.00 plus tax (Refund Policy)



To identify the prevalence, patterns and trends of illicit drug use in the general population of selected high-prevalence areas in China between 1993 and 2000. Design, setting and participants 

Cluster sampling was employed and the Epidemiological Inventory for Illicit Drug Use (EIIDU) used as survey instrument. In 1993, 1996 and 2000, 56 792, 67 319 and 53 747 individuals aged 15 or above in community were interviewed, respectively, at the three time-points. Measurements 

Demographics and drug-related data were collected and the prevalence patterns of illicit drug are described. Findings 

The life-time prevalences of illicit drug use in the three consecutive surveys in 1993, 1996 and 2000 were 1.08, 1.60 and 1.52%, respectively, and the 1-year prevalence rates were 0.91, 1.17 and 1.17%, respectively. Heroin was the first choice for drug use (51.8% in 1993, 83.4% in 1993 and 95.9% in 2000). The two most frequent routes of drug administration were inhalation (89.2% in 1993, 60.1% in 1996 and 93.5% in 2000) and intravenous injection (27.2% in 1993, 31.0% in 1996 and 25.7% in 2000). Conclusion 

At least for the time being, illicit drug use may have plateaued in these selected high-prevalence areas.

Keywords: Epidemiological survey; illicit drugs; prevalence rate; use patterns

Document Type: Research Article


Affiliations: Mental Health Institute, WHO Collaborating Center for Psychosocial Factor, Drug Abuse and Health, 2nd Xiangya Hospital of Central South University, Hunan, China

Publication date: 2004-09-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more